SOST and sclerosteosis 2: Sclerosteosis 2 has been mapped to the LRP4 gene where there is direct interaction between sclerostin and LRP4, and LRP4 facilitates sclerostin mediated WNT inhibition; which is implicated in LRP4 mutants [26, 27].